Search Results - Mark Hartmann

Mark Hartmann

Hartmann playing for [[Ubon United F.C.|Ubon United]] in 2018. Mark Andrew Calibjo Hartmann (born 20 January 1992) is a professional footballer who plays as a forward or an attacking midfielder for Philippines Football League club One Taguig. Born in England, he played for the Philippines national team. Provided by Wikipedia
  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Titanium as a Substrate for Three‐Dimensional Hybrid Electrodes for Vanadium Redox Flow Battery Applications by Xubin Lu, Dr. Fan Li, Dr. Matthias Steimecke, Muhammad Tariq, Mark Hartmann, Prof. Dr. Michael Bron

    Published in ChemElectroChem (2020-02-01)
    Get full text
    Article


  2. 2

    S122: MUTANT IDH1 HIJACKS DIFFERENTIATION PROGRAMS IN MYELOID PROGENITOR CELLS TO IMPAIR GRANULOCYTIC DIFFERENTIATION. by Mariam Hakobyan, Jens Langstein, Emely Kleinert, Maximilian Schönung, Mark Hartmann, Hannah Rohdjess, Sina Staeble, Rainer Claus, Lars Bullinger, Christopher Oakes, Karsten Rippe, Stefan Fröhling, Stefan Pusch, Christoph Plass, Michael Milsom, Daniel B. Lipka

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  3. 3

    Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions by Julia Schöpf, Sebastian Uhrig, Christoph E. Heilig, Kwang-Seok Lee, Tatjana Walther, Alexander Carazzato, Anna Maria Dobberkau, Dieter Weichenhan, Christoph Plass, Mark Hartmann, Gaurav D. Diwan, Zunamys I. Carrero, Claudia R. Ball, Tobias Hohl, Thomas Kindler, Patricia Rudolph-Hähnel, Dominic Helm, Martin Schneider, Anna Nilsson, Ingrid Øra, Roland Imle, Ana Banito, Robert B. Russell, Barbara C. Jones, Daniel B. Lipka, Hanno Glimm, Daniel Hübschmann, Wolfgang Hartmann, Stefan Fröhling, Claudia Scholl

    Published in Nature Communications (2024-01-01)
    Get full text
    Article


  4. 4

    ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT by Mark Hartmann, Maximilian Schönung, Jovana Rajak, Joschka Hey, Valentin Maurer, Ling Hai, Sina Staeble, Jens Langstein, Katharina Bauer, Mariam Hakobyan, Laura Jardine, Sheila Bohler, Dominik Vonficht, Abdul-Habib Maag, Dirk Lebrecht, Katrin M. Bernt, Roland Roelz, Tobias Boch, Eleonora Khabirova, Pavlo Lutsik, Simon Haas, Muzlifah Haniffa, Sam Behjati, Jan-Philipp Mallm, Christian Buske, Michael D. Milsom, Stefan Fröhling, Marc-Jan Bonder, Charlotte Niemeyer, Christian Flotho, Christoph Plass, Miriam Erlacher, Matthias Schlesner, Daniel B. Lipka

    Published in EJC Paediatric Oncology (2023-12-01)
    Get full text
    Article


  5. 5

    S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT by Mark Hartmann, Maximilian Schönung, Jovana Rajak, Joschka Hey, Valentin Maurer, Ling Hai, Sina Staeble, Jens Langstein, Katharina Bauer, Mariam Hakobyan, Laura Jardine, Sheila Bohler, Dominik Vonficht, Abdul-Habib Maag, Dirk Lebrecht, Kathrin Bernt, Roland Rölz, Tobias Boch, Eleonora Khabirova, Pavlo Lutsik, Simon Haas, Muzlifah Haniffa, Sam Behjati, Jan-Philipp Mallm, Christian Buske, Michael Milsom, Stefan Fröhling, Marc-Jan Bonder, Christoph Plass, Charlotte Niemeyer, Christian Flotho, Miriam Erlacher, Matthias Schlesner, Daniel B. Lipka

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


Search Tools: